NLRP3炎性小体在中枢神经系统疾病中的作用研究进展

doi:10.13418/j.issn.1001-165x.2022.1.24

中国临床解剖学杂志 ›› 2022, Vol. 40 ›› Issue (1): 113-116.doi: 10.13418/j.issn.1001-165x.2022.1.24

NLRP3炎性小体在中枢神经系统疾病中的作用研究进展

张鹏飞¹，　于春泽¹，　于建云²，　杨力¹*

昆明医科大学　1.人体解剖学与组织胚胎学系， 2.法医学院，昆明 650500

收稿日期:2020-08-26 出版日期:2022-01-25 发布日期:2022-01-19
通讯作者: 杨力，副教授，硕士生导师，电话: 13888566664，E-mail: yanglikm@163.com
作者简介:张鹏飞（1985-），男，河北承德人，在读硕士，主治医师，主要研究方向：神经退行性变，E-mail：56493654@qq.com
基金资助:
国家自然科学基金( 81060101)；云南省科技厅联合专项( 2018FE001-015 )；云南省创新团队项目（No. 202005AE160004）

New progress of the roles of NLRP3 inflammasomes in central nervous system diseases

Zhang Pengfei¹，Yu Chunze¹，Yu Jianyun²， Yang Li¹*

1.Department of Anatomy and Histology & Embryology, Kunming Medical University, Kunming 650500, China; 2. School of Forensic Medicine, Kunming Medical University, Kunming 650500, China

Received:2020-08-26 Online:2022-01-25 Published:2022-01-19

摘要/Abstract

关键词: NLRP3炎性小体, , , 炎性反映应, , , 中枢神经系统疾病

Key words: , NLRP3 inflammasome, , , Inflammatory response, , , Central nerrous system disease

中图分类号:

R363.21

张鹏飞, 于春泽, 于建云, 杨力. NLRP3炎性小体在中枢神经系统疾病中的作用研究进展[J]. 中国临床解剖学杂志, 2022, 40(1): 113-116.

Zhang Pengfei, Yu Chunze, Yu Jianyun, Yang Li. New progress of the roles of NLRP3 inflammasomes in central nervous system diseases[J]. Chinese Journal of Clinical Anatomy, 2022, 40(1): 113-116.

[1] Zhu S, Ding SY, Wang PH, et al. Nlrp9b inflammasome restricts rotavirus infection in intestinal epithelial cells[J]. Nature, 2017, 546(7660): 667-670. DOI: 10.1038/nature22967.
[2] Karki R, Kanneganti TD. Diverging inflammasome signals in tumorigenesis and potential targeting[J]. Nat Rev Cancer, 2019, 19(4): 197-214. DOI: 10.1038/s41568-019-0123-y.
[3] Liu W, Chen YH, Meng J, et al. Ablation of caspase-1 protects against TBI-induced pyroptosis in vitro and in vivo[J]. J Neuroinflammation, 2018, 15(1): 48. DOI: 10.1186/s12974-018-1083-y.
[4] O'Brien WT, Pham L, Symons GF, et al. The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic target[J]. J Neuroinflammation, 2020, 17(1): 104. DOI: 10.1186/s12974-020-01778-5.
[5] Xu X, Yin DP, Ren HL, et al. Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury[J]. Neurobiol Dis, 2018, 117: 15-27. DOI: 10.1016/j.nbd.2018.05.016.
[6] Wallisch JS, Simon DW, Bayir H, et al. Cerebrospinal fluid NLRP3 is increased after severe traumatic brain injury in infants and children[J]. Neurocrit Care, 2017, 27(1): 44-50. DOI: 10.1007/s12028-017-0378-7.
[7] Geng FY, Ma YH, Xing T, et al. Effects of hyperbaric oxygen therapy on inflammasome signaling after traumatic brain injury[J]. Neuroimmunomodulation, 2016, 23(2): 122-129. DOI: 10.1159/000445689.
[8] Severini C, Barbato C, Di Certo MG, et al. Alzheimer's disease: new concepts on the role of autoimmunity and of NLRP3 inflammasome in the pathogenesis of the disease[J]. Curr Neuropharmacol, 2020. DOI: 10.2174/1570159X18666200621204546.
[9] Abbott A. Is 'friendly fire' in the brain provoking Alzheimer's disease[J]? Nature, 2018, 556(7702): 426-428. DOI: 10.1038/d41586-018-04930-7.
[10]Zhang Y, Dong ZF, Song WH. NLRP3 inflammasome as a novel therapeutic target for Alzheimer's disease[J]. Signal Transduct Target Ther, 2020, 5(1): 37. DOI: 10.1038/s41392-020-0145-7.
[11]Ising C, Venegas C, Zhang SS, et al. NLRP3 inflammasome activation drives tau pathology[J]. Nature, 2019, 575(7784): 669-673. DOI: 10.1038/s41586-019-1769-z.
[12]Mao Z, Liu C, Ji S, et al. The NLRP3 inflammasome is involved in the pathogenesis of Parkinson's disease in rats[J]. Neurochem Res, 2017, 42(4): 1104-1115. DOI: 10.1007/s11064-017-2185-0.
[13]Qiao C, Zhang Q, Jiang QL, et al. Inhibition of the hepatic Nlrp3 protects dopaminergic neurons via attenuating systemic inflammation in a MPTP/p mouse model of Parkinson's disease[J]. J Neuroin flammation, 2018, 15(1): 193. DOI: 10.1186/s12974-018-1236-z.
[14]Lee JD, Kumar V, Fung JN, et al. Pharmacological inhibition of complement C5a-C5a1 receptor signalling ameliorates disease pathology in the hSOD1(G93A) mouse model of amyotrophic lateral sclerosis[J]. Br J Pharmacol, 2017, 174(8): 689-699. DOI: 10.1111/bph.13730.
[15]Bellezza I, Grottelli S, Costanzi E, et al. Peroxynitrite activates the NLRP3 inflammasome cascade in SOD1(G93A) mouse model of amyotrophic lateral sclerosis[J]. Mol Neurobiol, 2018, 55(3): 2350-2361. DOI: 10.1007/s12035-017-0502-x.
[16]Inoue M, Williams KL, Gunn MD, et al. NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis[J]. Proc Natl Acad Sci U S A, 2012, 109(26): 10480-10485. DOI: 10.1073/pnas.1201836109.
[17]Zhou KQ, Green CR, Bennet L, et al. The role of connexin and pannexin channels in perinatal bBrain injury and inflammation[J]. Front Physiol, 2019, 10: 141. DOI: 10.3389/fphys.2019.00141.
[18]Zhao J, Piao XY, Wu Y, et al. Cepharanthine attenuates cerebral ischemia/reperfusion injury by reducing NLRP3 inflammasome-induced inflammation and oxidative stress via inhibiting 12/15-LOX signaling[J]. Biomed Pharmacother, 2020, 127: 110151. DOI: 10.1016/j.biopha.2020.110151.
[19]Wang HN, Zhong D, Chen HP, et al. NLRP3 inflammasome activates interleukin-23/interleukin-17 axis during ischaemia-reperfusion injury in cerebral ischaemia in mice[J]. Life Sci, 2019, 227: 101-113. DOI: 10.1016/j.lfs.2019.04.031.
[20]Ye XC, Shen T, Hu JX, et al. Purinergic 2X7 receptor/NLRP3 pathway triggers neuronal apoptosis after ischemic stroke in the mouse[J]. Exp Neurol, 2017, 292: 46-55. DOI: 10.1016/j.expneurol.2017.03.002.
[21]Mohamadi Y, Noori Moghahi SMH, Mousavi M, et al. Intrathecal transplantation of Wharton's jelly mesenchymal stem cells suppresses the NLRP1 inflammasome in the rat model of spinal cord injury[J]. J Chem Neuroanat, 2019, 97: 1-8. DOI: 10.1016/j.jchemneu.2019.01.011.
[22]Su XQ, Wang XY, Gong FT, et al. Oral treatment with glycyrrhizin inhibits NLRP3 inflammasome activation and promotes microglial M2 polarization after traumatic spinal cord injury[J]. Brain Res Bull, 2020, 158: 1-8. DOI: 10.1016/j.brainresbull.2020.02.009.
[23]Wang SN, Guo XY, Tang J, et al. Expression and localization of absent in melanoma 2 in the injured spinal cord[J]. Neural Regen Res, 2019, 14(3): 542-552. DOI: 10.4103/1673-5374.245481.
[24]Ramaswamy V, Walsh JG, Sinclair DB, et al. Inflammasome induction in Rasmussen's encephalitis: cortical and associated white matter pathogenesis[J]. J Neuroinflammation, 2013, 10: 152. DOI: 10.1186/1742-2094-10-152.
[25]Yue J, Wei YJ, Yang XL, et al. NLRP3 inflammasome and endoplasmic reticulum stress in the epileptogenic zone in temporal lobe epilepsy: molecular insights into their interdependence[J]. Neuropathol Appl Neurobiol, 2020, 46(7): 770-785. DOI: 10.1111/nan.12621.
[26]Chen ML, Lin K, Lin SK. NLRP3 inflammasome signaling as an early molecular response is negatively controlled by miR-186 in CFA-induced prosopalgia mice[J]. Braz J Med Biol Res, 2018, 51(9): e7602. DOI: 10.1590/1414-431X20187602.
[27]Zhong ZY, Liang S, Sanchez-Lopez E, et al. New mitochondrial DNA synthesis enables NLRP3 inflammasome activation[J]. Nature, 2018, 560(7717): 198-203. DOI: 10.1038/s41586-018-0372-z.
[28]Christgen S, Place DE, Kanneganti TD. Toward targeting inflammasomes: insights into their regulation and activation[J]. Cell Res, 2020, 30(4): 315-327. DOI: 10.1038/s41422-020-0295-8.
[29]Kelley N, Jeltema D, Duan YH, et al. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation[J]. Int J Mol Sci, 2019, 20(13): 3328. DOI: 10.3390/ijms20133328.
[30]Samir P, Kesavardhana S, Patmore DM, et al. DDX3X acts as a live-or-die checkpoint in stressed cells by regulating NLRP3 inflammasome[J]. Nature, 2019, 573(7775): 590-594. DOI: 10.1038/s41586-019-1551-2.

NLRP3炎性小体在中枢神经系统疾病中的作用研究进展

New progress of the roles of NLRP3 inflammasomes in central nervous system diseases

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

本文评价

推荐阅读 0

[1]	江剑宏, 段仁鹏, 李晓锋. 国人胆道三维重建解剖变异应用研究[J]. 中国临床解剖学杂志, 2024, 42(1): 1-4.
[2]	郭红志, 王瑜, 张加琪, 梁海彬, 马梓玮, 冯伟, 吴忧, 司子燚. 血管铸型结合CT三维模型评估先兆子痫胎盘血管结构[J]. 中国临床解剖学杂志, 2024, 42(1): 5-10.
[3]	李佳伟, 张静, 李灿然, 兰文杰, 籍庆余, 郭志勇, 张云凤, 刘启, 陈清威, 李筱贺. 蒙古族人群股骨近端解剖参数X线测量[J]. 中国临床解剖学杂志, 2024, 42(1): 11-16.
[4]	李琨, 张燕, 郭冉, 郝咪咪, 吴轩宇, 徐艺芳, 王超群, 马文童, 张灵淇, 杨宏宇, 李志军, 张少杰, 王星. 儿童及青少年枕颈角与后枕颈角数字化测量及其临床意义[J]. 中国临床解剖学杂志, 2024, 42(1): 17-20.
[5]	李文, 杨思艺, 黄蕾, 卿霁雯, 蒋松涛, 张磊. 基于MRI探讨Lisfranc韧带的形态学特点及临床意义[J]. 中国临床解剖学杂志, 2024, 42(1): 21-25.
[6]	李凡凡, 徐阳, 王晓旭. 紫草素调节Nrf2/HO-1信号通路对实验性大鼠肉芽肿性小叶性乳腺炎的治疗作用研究[J]. 中国临床解剖学杂志, 2024, 42(1): 26-32.
[7]	王兴航, 丁佳媛, 李放, 包翠芬, 阎丽菁. 人参皂苷Rg1通过抑制NLRP3炎症小体途径减轻氧糖剥夺/复供后小胶质细胞炎症反应[J]. 中国临床解剖学杂志, 2024, 42(1): 33-41.
[8]	程莹莹, 武建军, 蔡海燕, 焦旭文, 马江波, 丁银秀. 体外炎性诱导星形胶质细胞激活及功能分析[J]. 中国临床解剖学杂志, 2024, 42(1): 42-46.
[9]	祁志, 杨力, 贾秋叶, 陈浩伦, 段兆达, 吴春云. 依达拉奉经MAPKs通路对脂多糖激活的小胶质细胞Sirt3表达调控[J]. 中国临床解剖学杂志, 2024, 42(1): 47-53.
[10]	张晶晶, 王洪新. 黄芩苷通过PDGF/P38 MAPK信号通路对肺动脉高压大鼠的保护作用[J]. 中国临床解剖学杂志, 2024, 42(1): 54-58.
[11]	乐钦, 陈荣丽, 熊婧熙, 王婷怡, 蔡志恒, 易秋实, 曾心怡. 白芨多糖对大鼠跨区皮瓣choke区的影响[J]. 中国临床解剖学杂志, 2024, 42(1): 59-64.
[12]	李笑予, 张磊, 付磊, 李东波, 汪国友. 三步接骨法治疗Sanders Ⅱ型跟骨骨折的有限元研究[J]. 中国临床解剖学杂志, 2024, 42(1): 65-70.
[13]	吴研飞, 马剑雄, 卢斌, 王颖, 柏豪豪, 靳洪震, 马信龙. CT后处理技术重建CT值与终板抗压强度的相关性研究[J]. 中国临床解剖学杂志, 2024, 42(1): 71-76.
[14]	庄万强, 唐毅, 骆勇刚, 张辉. 关节镜联合胫骨高位截骨术对髌骨位置及髌股关节功能影响的早中期回顾性研究[J]. 中国临床解剖学杂志, 2024, 42(1): 77-82.
[15]	罗鹰, 窦伟誉, 吴小杭, 陈璟昆, 彭昌贵, 潘剑英 . 微创海马钢板内固定治疗跟骨骨折并发症的影响因素[J]. 中国临床解剖学杂志, 2024, 42(1): 83-88.